 Russell Moore
Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocardial Reperfusion Injury | 8 | 2010 | 148 | 1.320 |
Why?
| | Physical Conditioning, Animal | 7 | 2008 | 253 | 1.300 |
Why?
| | Physiology | 1 | 2024 | 14 | 0.850 |
Why?
| | Myocardium | 8 | 2010 | 927 | 0.780 |
Why?
| | Myocytes, Cardiac | 5 | 2009 | 536 | 0.640 |
Why?
| | Cardiolipins | 6 | 2012 | 87 | 0.600 |
Why?
| | Biomedical Research | 1 | 2024 | 680 | 0.550 |
Why?
| | Rats | 17 | 2012 | 5594 | 0.450 |
Why?
| | Sarcolemma | 3 | 2009 | 42 | 0.420 |
Why?
| | Heart Failure | 6 | 2012 | 2093 | 0.400 |
Why?
| | KATP Channels | 3 | 2009 | 20 | 0.400 |
Why?
| | Hypertension | 4 | 2012 | 1251 | 0.390 |
Why?
| | Heart | 4 | 2012 | 620 | 0.380 |
Why?
| | Linoleic Acid | 2 | 2012 | 45 | 0.380 |
Why?
| | Myocardial Infarction | 3 | 2009 | 1069 | 0.340 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2012 | 197 | 0.320 |
Why?
| | Rats, Sprague-Dawley | 9 | 2012 | 2522 | 0.310 |
Why?
| | Exercise Test | 3 | 2007 | 623 | 0.310 |
Why?
| | Caloric Restriction | 1 | 2010 | 126 | 0.300 |
Why?
| | Mitochondria | 4 | 2012 | 974 | 0.290 |
Why?
| | Potassium Channels | 2 | 2007 | 148 | 0.290 |
Why?
| | Sodium-Calcium Exchanger | 2 | 2009 | 16 | 0.280 |
Why?
| | Protein Kinase C | 1 | 2009 | 252 | 0.280 |
Why?
| | Aging | 3 | 2010 | 1917 | 0.280 |
Why?
| | Coronary Circulation | 2 | 2009 | 136 | 0.270 |
Why?
| | Animals | 21 | 2024 | 37579 | 0.260 |
Why?
| | Rats, Inbred SHR | 6 | 2012 | 43 | 0.260 |
Why?
| | Benzamides | 2 | 2007 | 220 | 0.250 |
Why?
| | Dietary Fats | 1 | 2008 | 299 | 0.250 |
Why?
| | Physical Exertion | 1 | 2007 | 209 | 0.250 |
Why?
| | Ventricular Dysfunction, Left | 2 | 2007 | 375 | 0.250 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2007 | 119 | 0.250 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 143 | 0.250 |
Why?
| | Calcium | 4 | 2007 | 1190 | 0.240 |
Why?
| | Stress, Physiological | 2 | 2009 | 452 | 0.230 |
Why?
| | Sex Characteristics | 3 | 2009 | 785 | 0.210 |
Why?
| | Physical Education and Training | 1 | 2024 | 74 | 0.210 |
Why?
| | Diacetyl | 1 | 2003 | 8 | 0.210 |
Why?
| | Running | 2 | 2003 | 232 | 0.210 |
Why?
| | Exercise | 2 | 2024 | 2108 | 0.210 |
Why?
| | Cardiomyopathy, Hypertrophic, Familial | 1 | 2003 | 16 | 0.210 |
Why?
| | Hypertension, Renal | 1 | 2003 | 16 | 0.210 |
Why?
| | Adaptation, Physiological | 1 | 2007 | 562 | 0.200 |
Why?
| | History, 21st Century | 1 | 2024 | 218 | 0.200 |
Why?
| | History, 20th Century | 1 | 2024 | 325 | 0.190 |
Why?
| | Potassium Channels, Inwardly Rectifying | 3 | 2009 | 47 | 0.190 |
Why?
| | Sodium | 1 | 2003 | 195 | 0.190 |
Why?
| | Exercise Therapy | 1 | 2007 | 450 | 0.190 |
Why?
| | Glyburide | 1 | 2002 | 32 | 0.190 |
Why?
| | Citrate (si)-Synthase | 3 | 2007 | 60 | 0.180 |
Why?
| | Universities | 1 | 2024 | 449 | 0.180 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2002 | 214 | 0.160 |
Why?
| | Blotting, Western | 3 | 2009 | 1231 | 0.150 |
Why?
| | Models, Animal | 3 | 2007 | 393 | 0.140 |
Why?
| | Ventricular Function, Left | 3 | 2009 | 515 | 0.140 |
Why?
| | Myocardial Contraction | 3 | 2003 | 303 | 0.140 |
Why?
| | Disease Models, Animal | 4 | 2012 | 4407 | 0.140 |
Why?
| | Blood Pressure | 4 | 2012 | 1745 | 0.130 |
Why?
| | ATP-Binding Cassette Transporters | 2 | 2009 | 120 | 0.130 |
Why?
| | Kaplan-Meier Estimate | 2 | 2008 | 907 | 0.120 |
Why?
| | Rats, Inbred BN | 2 | 2007 | 56 | 0.120 |
Why?
| | Echocardiography | 2 | 2008 | 648 | 0.110 |
Why?
| | Hypoxia | 1 | 2002 | 1164 | 0.110 |
Why?
| | Male | 14 | 2012 | 69893 | 0.100 |
Why?
| | Colorado | 1 | 2024 | 4597 | 0.100 |
Why?
| | Rats, Inbred F344 | 2 | 2003 | 267 | 0.100 |
Why?
| | Rats, Mutant Strains | 2 | 2012 | 24 | 0.100 |
Why?
| | Hypoglycemic Agents | 1 | 2002 | 1368 | 0.090 |
Why?
| | Safflower Oil | 1 | 2012 | 5 | 0.090 |
Why?
| | Superoxide Dismutase | 2 | 2005 | 349 | 0.090 |
Why?
| | Patch-Clamp Techniques | 2 | 2003 | 293 | 0.090 |
Why?
| | Body Weight | 2 | 2007 | 992 | 0.090 |
Why?
| | Sex Factors | 2 | 2007 | 2051 | 0.090 |
Why?
| | Blood Vessels | 1 | 2012 | 180 | 0.090 |
Why?
| | Myocardial Ischemia | 2 | 2009 | 280 | 0.080 |
Why?
| | Sulfonylurea Receptors | 1 | 2009 | 5 | 0.080 |
Why?
| | Benzophenanthridines | 1 | 2009 | 10 | 0.080 |
Why?
| | Receptors, Drug | 1 | 2009 | 13 | 0.080 |
Why?
| | Protein Kinase C-epsilon | 1 | 2009 | 24 | 0.080 |
Why?
| | Phospholipases A2, Calcium-Independent | 1 | 2009 | 17 | 0.080 |
Why?
| | Subcellular Fractions | 1 | 2009 | 78 | 0.080 |
Why?
| | Female | 10 | 2009 | 75540 | 0.080 |
Why?
| | Enzyme Inhibitors | 2 | 2009 | 842 | 0.070 |
Why?
| | Metabolic Syndrome | 1 | 2012 | 348 | 0.070 |
Why?
| | Isoenzymes | 1 | 2009 | 301 | 0.070 |
Why?
| | Thromboxanes | 1 | 2008 | 17 | 0.070 |
Why?
| | Animal Feed | 1 | 2008 | 53 | 0.070 |
Why?
| | Diet, Fat-Restricted | 1 | 2008 | 78 | 0.070 |
Why?
| | Transcortin | 1 | 2007 | 15 | 0.070 |
Why?
| | Heart Ventricles | 2 | 2003 | 749 | 0.070 |
Why?
| | Motor Activity | 1 | 2012 | 718 | 0.070 |
Why?
| | HSP72 Heat-Shock Proteins | 1 | 2007 | 32 | 0.070 |
Why?
| | Dietary Carbohydrates | 1 | 2008 | 152 | 0.070 |
Why?
| | Adrenal Glands | 1 | 2007 | 80 | 0.070 |
Why?
| | Hypertrophy | 1 | 2007 | 134 | 0.070 |
Why?
| | Electron Transport Complex IV | 1 | 2007 | 62 | 0.060 |
Why?
| | Atrophy | 1 | 2007 | 196 | 0.060 |
Why?
| | Calcium-Binding Proteins | 1 | 2008 | 217 | 0.060 |
Why?
| | Mitochondria, Heart | 1 | 2007 | 102 | 0.060 |
Why?
| | Corticosterone | 1 | 2007 | 241 | 0.060 |
Why?
| | Phosphorylation | 1 | 2010 | 1758 | 0.060 |
Why?
| | Potassium Channel Blockers | 1 | 2006 | 47 | 0.060 |
Why?
| | Spleen | 1 | 2007 | 522 | 0.060 |
Why?
| | Fatty Acids | 1 | 2008 | 448 | 0.060 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2005 | 181 | 0.050 |
Why?
| | Up-Regulation | 1 | 2007 | 856 | 0.050 |
Why?
| | In Vitro Techniques | 2 | 2006 | 1093 | 0.050 |
Why?
| | Antioxidants | 1 | 2008 | 596 | 0.050 |
Why?
| | Ventricular Myosins | 1 | 2003 | 33 | 0.050 |
Why?
| | Sarcomeres | 1 | 2003 | 92 | 0.050 |
Why?
| | Diastole | 1 | 2003 | 142 | 0.050 |
Why?
| | Systole | 1 | 2003 | 175 | 0.050 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 2003 | 76 | 0.050 |
Why?
| | Microscopy, Electron | 1 | 2003 | 440 | 0.050 |
Why?
| | Oxidation-Reduction | 1 | 2007 | 1086 | 0.050 |
Why?
| | Disease Susceptibility | 1 | 2005 | 352 | 0.050 |
Why?
| | Caffeine | 1 | 2003 | 74 | 0.050 |
Why?
| | Amino Acid Substitution | 1 | 2003 | 309 | 0.050 |
Why?
| | Actin Cytoskeleton | 1 | 2003 | 103 | 0.050 |
Why?
| | Myosin Heavy Chains | 1 | 2003 | 180 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2003 | 398 | 0.050 |
Why?
| | Pacemaker, Artificial | 1 | 2003 | 117 | 0.050 |
Why?
| | Tibia | 1 | 2003 | 181 | 0.050 |
Why?
| | Mutation, Missense | 1 | 2003 | 340 | 0.040 |
Why?
| | Ion Channel Gating | 1 | 2002 | 92 | 0.040 |
Why?
| | Potassium | 1 | 2002 | 148 | 0.040 |
Why?
| | Time Factors | 2 | 2009 | 6944 | 0.040 |
Why?
| | Mice | 2 | 2010 | 18057 | 0.040 |
Why?
| | Action Potentials | 1 | 2003 | 499 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2002 | 490 | 0.040 |
Why?
| | Obesity | 1 | 2012 | 3000 | 0.040 |
Why?
| | Cells, Cultured | 1 | 2007 | 4199 | 0.040 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2003 | 771 | 0.040 |
Why?
| | Gene Expression | 1 | 2003 | 1490 | 0.040 |
Why?
| | Mice, Transgenic | 1 | 2003 | 2176 | 0.040 |
Why?
| | Humans | 3 | 2024 | 140898 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2007 | 1750 | 0.030 |
Why?
| | Age Factors | 1 | 2003 | 3278 | 0.030 |
Why?
| | Phenotype | 1 | 2003 | 3172 | 0.030 |
Why?
| | Signal Transduction | 1 | 2007 | 5148 | 0.030 |
Why?
| | Uncoupling Protein 3 | 1 | 2012 | 8 | 0.020 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2012 | 41 | 0.020 |
Why?
| | Ion Channels | 1 | 2012 | 130 | 0.020 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2012 | 199 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2007 | 11125 | 0.020 |
Why?
| | Oxidative Phosphorylation | 1 | 2012 | 204 | 0.020 |
Why?
| | Mitochondrial Proteins | 1 | 2012 | 260 | 0.020 |
Why?
| | Aorta | 1 | 2012 | 423 | 0.020 |
Why?
| | Tissue Survival | 1 | 2009 | 18 | 0.020 |
Why?
| | Phosphatidylglycerols | 1 | 2009 | 20 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 2012 | 447 | 0.020 |
Why?
| | Aged | 1 | 2007 | 24666 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2012 | 1325 | 0.010 |
Why?
| | Chromatography, Gas | 1 | 2005 | 33 | 0.010 |
Why?
| | Middle Aged | 1 | 2007 | 34487 | 0.010 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2005 | 136 | 0.010 |
Why?
| | Cytokines | 1 | 2012 | 2092 | 0.010 |
Why?
| | Reference Standards | 1 | 2005 | 185 | 0.010 |
Why?
| | Transcription Factors | 1 | 2012 | 1703 | 0.010 |
Why?
| | Adult | 1 | 2007 | 39134 | 0.010 |
Why?
| | Phospholipids | 1 | 2005 | 221 | 0.010 |
Why?
| | Mass Spectrometry | 1 | 2005 | 740 | 0.010 |
Why?
|
|
Moore's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|